Prognostic value of computed tomography derived skeletal muscle mass index in lung cancer: A meta-analysis
- PMID: 36051119
- PMCID: PMC9297422
- DOI: 10.12998/wjcc.v10.i20.6927
Prognostic value of computed tomography derived skeletal muscle mass index in lung cancer: A meta-analysis
Abstract
Background: The prognostic role of the skeletal muscle mass index (SMI) derived from computed tomography (CT) imaging been well verified in several types of cancers. However, whether the SMI could serve as a reliable and valuable predictor of long-term survival in lung cancer patients remains unclear.
Aim: To identify the prognostic value of the CT-derived SMI in lung cancer patients.
Methods: The PubMed, Web of Science, and Embase electronic databases were searched up to November 5, 2021 for relevant studies. The Reference Citation Analysis databases were used during the literature searching and selection. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated to assess the association of the SMI with the overall survival (OS) of lung cancer patients. All statistical analyses were performed with STATA 12.0 software.
Results: A total of 12 studies involving 3002 patients were included. The pooled results demonstrated that a lower SMI was significantly related to poorer OS (HR = 1.23, 95%CI: 1.11-1.37, P < 0.001). In addition, the subgroup analyses stratified by treatment (nonsurgery vs surgery), tumor stage (advanced stage vs early stage), and tumor type (non-small cell lung cancer vs lung cancer) showed similar results.
Conclusion: The CT-derived SMI is a novel and valuable prognostic indicator in lung cancer and might contribute to the clinical management and treatment of lung cancer patients.
Keywords: Computed tomography; Lung cancer; Meta-analysis; Prognosis; Skeletal muscle mass index.
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Figures




Similar articles
-
Prognostic Value of Pretreatment Skeletal Muscle Mass Index in Esophageal Cancer Patients: A Meta-Analysis.Nutr Cancer. 2022;74(10):3592-3600. doi: 10.1080/01635581.2022.2088814. Epub 2022 Jun 22. Nutr Cancer. 2022. PMID: 35730425
-
Prognostic value of pretreatment skeletal muscle index in pancreatic carcinoma patients: A meta-analysis.Medicine (Baltimore). 2023 May 12;102(19):e33663. doi: 10.1097/MD.0000000000033663. Medicine (Baltimore). 2023. PMID: 37171343 Free PMC article.
-
Prognostic role of pretreatment skeletal muscle index in gastric cancer patients: A meta-analysis.Pathol Oncol Res. 2023 Apr 24;29:1611055. doi: 10.3389/pore.2023.1611055. eCollection 2023. Pathol Oncol Res. 2023. PMID: 37168049 Free PMC article.
-
Looking at or beyond the tumor - a systematic review and meta-analysis of quantitative imaging biomarkers predicting pancreatic cancer prognosis.Abdom Radiol (NY). 2025 Apr 8. doi: 10.1007/s00261-025-04919-7. Online ahead of print. Abdom Radiol (NY). 2025. PMID: 40195140 Review.
-
The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: a systematic review and meta-analysis.BMC Cancer. 2018 Dec 10;18(1):1235. doi: 10.1186/s12885-018-5136-5. BMC Cancer. 2018. PMID: 30526532 Free PMC article.
Cited by
-
Predictive role of pretreatment skeletal muscle mass index for long-term survival of bladder cancer patients: A meta-analysis.PLoS One. 2023 Jun 30;18(6):e0288077. doi: 10.1371/journal.pone.0288077. eCollection 2023. PLoS One. 2023. PMID: 37390088 Free PMC article.
-
Evaluation of nutritional parameters that may be associated with survival in patients with locally advanced non-small cell lung carcinoma receiving definitive concurrent chemoradiotherapy: retrospective study conducted in a tertiary pulmonary hospital.Jpn J Radiol. 2025 Mar;43(3):422-433. doi: 10.1007/s11604-024-01692-3. Epub 2024 Nov 14. Jpn J Radiol. 2025. PMID: 39538069
References
-
- Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021 - PubMed
-
- American Cancer Society Cancer Statistics 2021 Report. J Nucl Med. 2021;62:12N. - PubMed
-
- Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71:7–33. - PubMed
LinkOut - more resources
Full Text Sources